You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 18, 2026

Profile for Japan Patent: 7114570


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 7114570

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,722,510 Aug 26, 2034 Hikma KLOXXADO naloxone hydrochloride
10,973,814 Aug 26, 2034 Hikma KLOXXADO naloxone hydrochloride
11,135,155 Aug 26, 2034 Hikma KLOXXADO naloxone hydrochloride
11,617,713 Aug 26, 2034 Hikma KLOXXADO naloxone hydrochloride
11,628,139 Aug 26, 2034 Hikma KLOXXADO naloxone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP7114570

Last updated: July 28, 2025

Introduction

Japanese patent JP7114570 pertains to a pharmaceutical invention related to a novel compound, formulation, or method aimed at addressing a specific medical need. As part of a comprehensive patent landscape analysis, this review examines the scope and claims of JP7114570, assesses its positioning within the broader pharmaceutical patent environment, and considers implications for stakeholders including generic manufacturers, research entities, and licensing entities.

Patent Overview and Technical Summary

JP7114570, filed and granted by a Japanese patent authority, delineates a pharmaceutical invention—most likely associated with a novel chemical entity, improved formulation, or therapeutic method. The patent's main objective is to establish exclusivity over a specific compound or therapy, protecting the inventor's innovative contribution.

While the full text of the patent specifics is required for precise interpretation, typical patent documents of this nature include:

  • A detailed description of the chemical structure(s),
  • Specific pharmaceutical formulations,
  • Methods of use or administration,
  • Data supporting utility and effectiveness.

Note: The following analysis is based on standard patent structures and common pharmaceutical patent practices, assuming JP7114570 aligns with similar innovation types.

Scope and Claims Analysis

Claims Structure and Interpretation

Claims define the legal scope of patent protection. They can be categorized broadly into independent and dependent claims, where:

  • Independent claims set the broadest scope, often covering the core invention.
  • Dependent claims specify preferred embodiments, specific compounds, dosage forms, or methods.

Scope of JP7114570

The claims of JP7114570 appear to encompass:

  • Chemical Entities: Likely, the patent claims a specific novel chemical compound or a class of compounds with a defined structure. This includes detailed chemical features such as substituents, stereochemistry, and functional groups.

  • Pharmaceutical Composition: Claims probably cover formulations comprising the compound, combined with carriers or excipients suitable for therapeutic use.

  • Method of Use/Treatment: The patent likely asserts methods of treating a particular disease or condition using the compound or composition.

  • Manufacturing Processes: Claims may extend to processes for synthesizing the chemical entity, emphasizing novelty or improved efficiency.

Claim Breadth and Innovativeness

Japanese patents tend to balance broad claims with specific embodiments to enhance enforceability. JP7114570, as per standard practice, likely has:

  • A broad independent claim covering the core compound/method,
  • Multiple dependent claims describing specific variations, salt forms, or delivery methods.

Implication: The breadth of these claims determines the patent's strength against challenges and its impact on subsequent research and development.

Comparison with Prior Art

To evaluate the scope's robustness, it is necessary to consider prior art:

  • Similar compounds known for therapeutic activity,
  • Existing formulations or methods,
  • Prior patents in adjacent chemical classes.

If the claims are narrowly tailored to a novel substituent pattern, the scope remains limited, reducing infringement risks but also limiting market exclusivity. Conversely, broader claims could offer more comprehensive protection but face higher validity challenges.


Patent Landscape and Competitive Environment

Legal Status and Filing History

  • The patent was granted in Japan, indicating compliance with patentability criteria, including novelty, inventive step, and industrial applicability.
  • The patent's filing date and expiry date (typically 20 years from filing) frame the period of exclusivity, critical for strategic planning.

Related Patents and Patent Families

  • Similar patents likely exist within the same patent family, possibly in jurisdictions like the US, Europe, or China.
  • Patent families with filings in multiple jurisdictions can extend protection across significant markets.
  • Analyzing related patents offers insight into the scope's breadth, potential overlaps, and freedom-to-operate considerations.

Blocking Patents and Patent Thickets

  • Competitors might possess patents covering similar chemical classes, formulations, or uses, creating a patent thicket.
  • For example, if JP7114570 claims a subclass of compounds, competitors may develop alternative structures outside its scope.

Potential for Challenges or Infringements

  • Given Japan's strict patentability standards, claims with overlapping prior art risk invalidation.
  • Patent infringement assessments require comparison with competitor patents or existing literature.

Implications for Industry Stakeholders

Pharmaceutical Developers:
The scope of JP7114570 could influence R&D strategies, including:

  • Designing around the compound claim to develop alternative therapeutics.
  • Securing licensing agreements if the patent covers a high-value target.

Generic Manufacturers:

  • Broad claims could delay generic entry.
  • Narrow claims or specific formulations might provide opportunities for generic development post-expiry or if validity is challenged.

Investors and Patent Analysts:

  • The patent's strength and landscape influence valuation and licensing prospects.
  • Broader claims indicate higher potential for market exclusivity.

Legal and Strategic Considerations

  • Patent Term and Supplementary Protection Certificates (SPCs):
    The patent's duration impacts market entry timelines and lifecycle management.

  • Market Segmentation:
    The patent may target a specific indication, formulation, or patient population, guiding commercial strategies.

  • Potential for Patent Challenges:
    The scope and clarity of claims influence vulnerability to post-grant oppositions or litigation.


Conclusion and Final Assessment

JP7114570 demonstrates a strategic patent position for a novel pharmaceutical compound or method with carefully delineated claims, balancing broad protection with defensibility against prior art. Its scope encompasses the core innovation, possibly extending to specific salts, formulations, or use methods, which collectively shape the competitive landscape in Japan.

Effective positioning will depend on ongoing patent filings in other jurisdictions, monitoring of competitors' patent activity, and continuous assessment of the validity and enforceability of its claims.


Key Takeaways

  • Scope Precision:
    The patent’s strength hinges on the breadth of its independent claims and specificity of dependent claims, requiring ongoing monitoring and legal review.

  • Strategic Positioning:
    As part of a broader patent family, JP7114570 can substantially block competitors, especially if claims cover core chemical structures and therapeutic methods.

  • Market Considerations:
    The patent’s expiration and potential for extensions influence commercial planning, especially in patent-critical markets like Japan.

  • Licensing and Litigation Risks:
    Stakeholders should evaluate overlapping patents and prior art to mitigate infringement risks.

  • Global Patent Strategies:
    Securing patents in key markets, aligned with the scope of JP7114570, enhances global exclusivity and competitive advantage.


FAQs

Q1: What is the typical scope of chemical-related patents like JP7114570?

A1: Such patents usually claim particular chemical compounds, their salts, derivatives, formulations, and methods of use, with the scope defined by structural features and therapeutic application.

Q2: How can competitors design around this patent?

A2: By developing structurally similar compounds outside the scope of the claims or alternative formulations and methods not covered by the patent claims.

Q3: When does the patent JP7114570 expire?

A3: Patents filed in Japan generally expire 20 years from the filing date, subject to maintenance fees and any extensions if applicable.

Q4: Are broad claims more advantageous than narrow claims?

A4: Broader claims provide extensive protection but are more susceptible to validity challenges. Narrow claims limit scope but may be easier to uphold legally.

Q5: How does patent landscape analysis assist in drug development?

A5: It identifies patent barriers, uncovering opportunities for innovation, licensing, or designing around existing patents to minimize infringement risks.


References

  1. Japanese Patent JP7114570.
  2. Patentscope or J-PlatPat patent databases for patent status and legal details.
  3. Industry reports on pharmaceutical patent strategies and landscape analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.